SCHEMBL1609511

SCHEMBL1609511

CCOC(=O)C=Cc1c[nH]c2c(C#N)cc(F)cc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ATM Q13315 1/20 0.41
EPAS1 Q99814 1/20 0.38
CCNC P24863 2/20 0.36
CDK8 P49336 2/20 0.36
DPP4 P27487 2/20 0.36
TTR P02766 1/20 0.36
NR1H4 Q96RI1 3/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
CA14 Q9ULX7 1/20 0.35
TDO2 P48775 1/20 0.35
CYP3A4 P08684 1/20 0.34
ESR1 P03372 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1609509 1.00 MAPT (0.41) MAPTMEN1KMT2AKDM4EATM
SCHEMBL3417898 0.83 TDO2 (0.50) MAPTMEN1KMT2AKDM4ECA1
SCHEMBL3417896 0.83 TDO2 (0.50) MAPTMEN1KMT2AKDM4ECA1
SCHEMBL1609422 0.80 MAPT (0.46) MAPTMEN1KMT2AKDM4EATM
SCHEMBL1609424 0.80 MAPT (0.46) MAPTMEN1KMT2AKDM4EATM
SCHEMBL1420948 0.78 MAPT (0.43) MAPTMEN1KMT2AKDM4EATM
SCHEMBL1420951 0.78 MAPT (0.43) MAPTMEN1KMT2AKDM4EATM
SCHEMBL1420294 0.78 MAPT (0.39) MAPTMEN1KMT2AKDM4EATM
SCHEMBL1420290 0.78 MAPT (0.39) MAPTMEN1KMT2AKDM4EATM
SCHEMBL11353377 0.77 TTR (0.44) MAPTMEN1KMT2AEPAS1DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110086839-A1 COMPOUNDS GLAXO GROUP LIMITED (GB) 2011-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110086839-A1 COMPOUNDS CYP11B2, CYP11B1, GLS2 MAPT 1092/4885MEN1 2901/4885KMT2A 4598/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.